TARTAGLIONE, Immacolata
 Distribuzione geografica
Continente #
EU - Europa 2.988
AS - Asia 1.027
NA - Nord America 989
SA - Sud America 205
AF - Africa 25
OC - Oceania 2
Totale 5.236
Nazione #
RU - Federazione Russa 2.085
US - Stati Uniti d'America 968
SG - Singapore 385
IE - Irlanda 296
IT - Italia 255
CN - Cina 219
HK - Hong Kong 201
BR - Brasile 168
DE - Germania 102
GB - Regno Unito 80
VN - Vietnam 57
KR - Corea 50
JP - Giappone 32
IN - India 29
UA - Ucraina 29
FR - Francia 25
GR - Grecia 22
FI - Finlandia 18
AR - Argentina 17
AT - Austria 14
SE - Svezia 14
PK - Pakistan 12
BD - Bangladesh 10
BE - Belgio 10
CA - Canada 10
NL - Olanda 10
ZA - Sudafrica 9
CH - Svizzera 8
MX - Messico 8
TR - Turchia 8
ID - Indonesia 6
VE - Venezuela 6
EC - Ecuador 5
CO - Colombia 4
DZ - Algeria 4
ES - Italia 4
IL - Israele 4
CL - Cile 3
MA - Marocco 3
PL - Polonia 3
UZ - Uzbekistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TW - Taiwan 1
Totale 5.236
Città #
Moscow 754
Dublin 287
Hong Kong 201
Singapore 175
Santa Clara 168
Chandler 122
Jacksonville 66
Seoul 50
Caserta 43
Beijing 42
New York 42
Princeton 38
Roxbury 38
Ann Arbor 36
Ashburn 34
Bremen 33
Hefei 33
Munich 32
Naples 32
Grumo Nevano 21
Cambridge 20
Dallas 20
Ercolano 20
Bengaluru 19
Ho Chi Minh City 19
Medford 19
The Dalles 17
Wilmington 17
Woodbridge 17
Des Moines 13
Nuremberg 12
Los Angeles 11
Nanjing 11
Boardman 10
Brussels 10
Hanoi 10
Rome 10
São Paulo 10
Helsinki 9
Milan 9
Vienna 9
Amsterdam 8
Johannesburg 8
London 8
Napoli 8
Pozzuoli 8
Falkenstein 7
Redwood City 7
Brooklyn 6
Da Nang 6
Nanchang 6
Turku 6
Belo Horizonte 5
Montreal 5
Orlando 5
Rio de Janeiro 5
Biên Hòa 4
Bologna 4
Campinas 4
Curitiba 4
Fairfield 4
Haiphong 4
Salvador 4
San Mateo 4
Shanghai 4
Taizhou 4
Tokyo 4
Aversa 3
Boston 3
Brasília 3
Chicago 3
Guangzhou 3
Istanbul 3
Lahore 3
Mexico City 3
Poplar 3
Quito 3
Ribeirão Preto 3
Shenyang 3
Stockholm 3
Takoma Park 3
Tashkent 3
Tel Aviv 3
Tianjin 3
Abidjan 2
Araraquara 2
Asunción 2
Bandung 2
Belgrade 2
Bogotá 2
Brno 2
Buenos Aires 2
Caracas 2
Caxias do Sul 2
Council Bluffs 2
Dourados 2
Elora 2
Guayaquil 2
Harbin 2
Kunming 2
Totale 2.764
Nome #
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 203
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 202
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 158
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 156
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 156
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 150
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 147
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 144
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 139
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 137
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 136
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 135
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 133
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 130
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 126
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 124
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 123
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 122
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 120
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 116
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 114
Brain perfusion changes in beta-thalassemia 111
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 109
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 108
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 106
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 97
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 97
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 97
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 96
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 95
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 94
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 91
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 88
Hearing loss in beta-thalassemia: Systematic review 88
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 81
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 81
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 81
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 79
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 78
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 76
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 70
Cognitive impairment in hereditary spherocytosis 67
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 67
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 65
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 65
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 65
Pregnancy and childbirth in women with thalassemia: past and present 65
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 63
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 59
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 53
Totale 5.363
Categoria #
all - tutte 18.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.985


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 16 22 6 6 12 24 2
2021/2022279 6 4 5 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025878 2 7 5 20 131 102 166 86 131 81 87 60
2025/20262.908 128 152 176 172 345 1.935 0 0 0 0 0 0
Totale 5.363